Live Breaking News & Updates on Acurx Pharmaceuticals Price Performance

Stay updated with breaking news from Acurx pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Trims Acurx Pharmaceuticals (NASDAQ:ACXP) Target Price to $12.00

HC Wainwright Trims Acurx Pharmaceuticals (NASDAQ:ACXP) Target Price to $12.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Acurx Pharmaceuticals Price Performance , Prospect Financial Services , Global Capital , Acurx Pharmaceuticals , Blackrock Inc , Vanguard Group Inc , News Ratings For Acurx Pharmaceuticals Daily , Northern Trust Corp , Acurx Pharmaceuticals Inc , Free Report , Financial Services , Trust Corp , Get Free Report , Acurx Pharmaceuticals Daily ,

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 6,700 shares, a drop of 51.1% from the August 31st total of 13,700 shares. Based on an average daily volume of 35,000 shares, the days-to-cover ratio […] ....

Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Blackrock Inc , Osaic Holdings Inc , Acurx Pharmaceuticals Price Performance , News Ratings For Acurx Pharmaceuticals Daily , Global Capital , Get Free Report , Acurx Pharmaceuticals Daily , Nasdaq Acxp ,

Short Interest in Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Drops By 52.8%

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating) saw a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 29,400 shares, a decrease of 52.8% from the March 15th total of 62,300 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average […] ....

News Ratings For Acurx Pharmaceuticals Daily , Acurx Pharmaceuticals , Acurx Pharmaceuticals Price Performance , Acurx Pharmaceuticals Company Profile , Armistice Capital , Acurx Pharmaceuticals Inc , Get Rating , Acurx Pharmaceuticals Daily , Nasdaq Acxp ,

Acurx Pharmaceuticals' (ACXP) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research note issued to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $14.00 price target on the stock. Acurx Pharmaceuticals Price Performance ACXP opened at $2.96 on Tuesday. The firm has a 50 day simple […] ....

Armistice Capital , Acurx Pharmaceuticals , Securities Exchange Commission , Acurx Pharmaceuticals Inc , News Ratings For Acurx Pharmaceuticals Daily , Acurx Pharmaceuticals Price Performance , Get Rating , Acurx Pharmaceuticals Daily , Nasdaq Acxp , Reiterated Rating , Hc Wainwright ,

HC Wainwright Reaffirms "Buy" Rating for Acurx Pharmaceuticals (NASDAQ:ACXP)

HC Wainwright reaffirmed their buy rating on shares of Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. Acurx Pharmaceuticals Price Performance Acurx Pharmaceuticals stock opened at $2.86 on Tuesday. The company has a market […] ....

News Ratings For Acurx Pharmaceuticals Daily , Acurx Pharmaceuticals , Securities Exchange Commission , Institutional Investors Weigh In On Acurx Pharmaceuticals , Armistice Capital , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals Price Performance , Get Rating , Acurx Pharmaceuticals Daily , Nasdaq Acxp , Reiterated Rating , Hc Wainwright ,